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Abstract
Background: Evidence based medicine (EBM) has made a substantial impact on primary care in Spain over the last
few years. However, little research has been done into family physicians (FPs)’ attitudes related to EBM. The present
study investigates FPs’ perceptions of EBM in the primary care context.
Methods: This study used qualitative methodology. Information was obtained from 8 focus groups composed of
67 FPs from 47 health centers in 4 autonomous regions in Spain. Intentional sampling considered participants’
previous education in EBM, and their experience as tutors in family medicine or working groups’ members of the
Spanish Society of Family Practice. Sociological discourse analysis was used with the support of the MAXqda
software. Results were validated by means of triangulation among researchers and contrast with participants.
Results: Findings were grouped into three main areas: 1) The tug-of-war between the “science” of EBM and
“experience” in the search for good clinical practice in primary care; 2) The development of EBM sensemaking as a
reaction to contextual factors and interests; 3) The paradox of doubt and trust in the new EBM experts.
The meaning of EBM was dynamically constructed within the primary care context. FPs did not consider good
clinical practice was limited to the vision of science that EBM represents. Its use appeared to be conditioned by
several factors that transcended the common concept of barriers. Along with concerns about its objectivity,
participants showed a tendency to see EBM as the use of simplified guidelines developed by EBM experts.
Conclusions: The identification of science with EBM and its recognition as a useful but insufficient tool for the
good clinical practice requires rethinking new meanings of evidence within the primary care reality. Beyond the
barriers related to accessing and putting into practice the EBM, its reactive use can determine FPs’ questions and
EBM development in a direction not always centred on patients’ needs. The questioning of experts’ authority as a
pillar of EBM could be challenged by the emergence of new kinds of EBM texts and experts to believe in.
Background
There is now no doubt that evidence-based medicine
(EBM) plays an important role in health care. EBM was
first presented in the early 1990s as a new movement
orientated towards “integrating individual clinical exper-
tise with the best available external clinical evidence
from systematic research” [1]. On one hand it was about
questioning non-rigorous clinical observations, physio-
pathological rationale and experts’ authority as reliable
pillars of medical knowledge [2], and on the other, it
proposed the need for new skills: formulation of well
structured questions, search and retrieval of the best
available evidence, and critical assessment of available
medical literature. The instruments have since evolved
tremendously in relation to access to and interpretation
of information, and the production of evidence-based
clinical practice guidelines (CPG).
Nevertheless, discussion and debate abound. From a
theoretical point of view, EBM has been questioned as
being reductionist and rigid with its hierarchical
approach to the concept of evidence [3-5]. At a practical
level, EBM has not been widely incorporated into clini-
cal decisions, drawing attention to the potential barriers
related to its implementation [6,7].
All these aspects are especially relevant in primary
care (PC). Studies undertaken in several countries have
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tive attitude towards EBM but they also emphasize the
importance of certain obstacles to its implementation.
The most important of these barriers appears to be the
lack of time, training and resources available [8-11] and
the complexity and individuality of clinical practice
[12,13]. EBM training has increased in Spain over the
last decade, and the new teaching curriculum in family
medicine promotes awareness of EBM and the use of
Internet resources in clinical practice. However, only a
few local studies have studied FPs’ thoughts about EBM
[14]. We therefore considered it relevant to carry out a
two-phase project, described in a previous publication
[15]. Here we present the results of a qualitative multi-
center study that aimed to investigate in depth FPs’ atti-
tudes and perceptions to EBM in our setting.
Methods
Qualitative methods have proved specially appropriate in
the approach to perceptions, beliefs and attitudes in stu-
dies related to EBM in PC [14,16-20]. In this qualitative
study focused on health services research [21,22] we
used group interviews [23,24] to generate information.
We selected a total of 8 focus groups with 67 FPs work-
ing in 47 different public health centres of 4 autono-
mous regions in Spain (Galicia, Euskadi, Madrid and
Catalonia) (Table 1). Two of the groups included work-
ing group members of the Spanish Society of Family
Practice (GS1, GS2) and two included family medicine
tutors (GT1, GT2). Two of the four remaining groups
had some type of EBM training (GTR1, GTR2) and two
did not (GTR3, GTR4).
Participants - 37 men (M) and 30 women (W) - were
intentionally selected and the recruiting process stressed
that the study was not an attempt to evaluate their
knowledge about EBM. Its independent nature was also
made clear. Confidentiality was guaranteed and a state-
ment of informed consent was obtained from all partici-
pants. The Ethics Committee at Hospital de la Santa
Creu i Sant Pau in Barcelona approved the study.
The focus groups met between October 2007 and July
2008 in health care centres and health care institutions.
Meetings lasted between one and two hours and a mod-
erator and an observer were present. The questionnaire
was semi-structured, and it was modified and adapted
according to the findings and group dynamics [23]. All
sessions were recorded. The two researchers made notes
in a field diary after each meeting.
Information generated was recorded in digital format.
Material was transcribed verbatim. It was verified by the
interviewers and field notes were added. Analysis was
done following the model of sociological discourse analy-
sis [25,26]. Using this model, the reading, organization
and interpretation of data does not come from a frag-
mentation of texts but from a more global view, keeping
in mind the context in which data were generated. The
findings were identified in accordance with the study
objectives and mapped firstly for each of the groups and
also contrasted with the others taking into account their
composition characteristics. Finally some common areas
and axes were built to synthesize the main results. Each
step in the process of interpretation and synthesis
required iterative revision of texts to identify and code
the main patterns and categories, and to corroborate the
Table 1 Participants
Groups N°
participants
N°
involved
Health Centres
Gender Age Years of work
men women mean range mean range
semFYC groups
Madrid (GS1)
9 7 6 3 40 30-49 17 16-24
semFYC groups
Barcelona (GS2)
6 6 4 2 46 38-55 17 7-30
Tutors
Donostia (GT1)
7 7 2 5 47 45-54 18 8-21
Tutors
Barcelona (GT2)
12 3 8 4 44 35-51 18 7-28
FP with training
Barcelona (GTR1)
12 7 5 7 35 28-43 8 2-18
FP with training
Donostia (GTR2)
9 7 5 4 49 35-58 21 7-30
FP without training
Coruña (GTR3)
7 6 4 3 46 30-53 24 18-32
FP without training
Madrid (GTR4)
5 4 3 2 35 32-41 7 3-10
Total 67 47 37 30 39 28-58 16 2-32
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data and to select the most representative verbatim state-
ments. The analytical process and results were discussed
and consensus was reached by triangulation among
researchers, and the preliminary report was also sent to
-and accepted by- the participants (“member checking”),
as procedures to improve the validity of the study [27].
Results
Analysis of the information collected showed that there
were not clear patterns linked to the characteristics of
the groups. Perhaps due to the variability in training
and knowledge about EBM within some of them, or
because the arisen concerns and narratives were not
necessarily related to this factor, the main findings
emerged across the different groups and could be classi-
fied into three areas. As these areas were inter-related,
an overall interpretation should be kept in mind.
1) EBM, science, experience and good clinical practice in PC
We found that the current status and importance of EBM
was widely recognized but rarely concretely defined. EBM
tended to be identified through certain features related to
“science” although this identification was often applied
“by defect”, that is, through components of professional
practice that are “outside” the scope of EBM and grouped
in the category “experience”. In both cases arguments and
questions sought justification in “good patient care”
(Figure 1).
Identifying EBM with “science” was mainly linked to
the requirements for objectivity when reviewing pub-
lished medical literature. In this sense, EBM generated
security, confidence and tranquillity.E B Ma s“science”
was occasionally linked to the accuracy of numbers, as
opposed to the imprecision of most of the symptoms
expressed by patients in the PC context.
“Well, it’s similar.... I’m thinking of scientific articles, or
scientific publications that allow you to improve a bit
daily practice with knowledge that is based on evidence.”
(M1)(GTR1).
“It also at times gives me a sense of security. When
they say something is so, I believe it is so. The problem is
that I believe there is still much not known...”(W3)
(GT1).
“I believe it’s the future, and actually as there is more
and more information on the Internet EBM will be more
powerful. There’s not going to be any other way to relate.
Because it’s giving you results with numbers, and that’s
what we doctors want” (M1)(GS1)
Also from the perspective of “science”, EBM was seen
in some discourses as a method of reviewing one’sh a b i -
tual clinical work in a critical manner and posing ques-
tions to be answered based on findings from published
studies.
“I insist on...that it is an instrument, and agree in the
sense that it is an instrument that is useful especially as
a method, as W4 was saying, to ask structured questions
and try to find the answers....” (M2)(GS2).
The role of EBM in clinical practice was, however,
repeatedly seen as relative and even questionable. Knowl-
edge accumulated over years of treating patients in
uncertain situations was mentioned as an important
component of professional work, confronting certain per-
ceptions of EBM which were seen as dogma. “Experience”
t h e r e f o r ec a m eu pi na l lt h eg r o u p si nc o n t r a p o s i t i o n /
complement to EBM.
“-...The matter is that... I know that EBM is important,
but you also have to place before it the experience you
have, don’t you? (W2).
-Y o uc a n ’t work based only on the evidence! First
come your experience and knowledge, until you are
proved wrong, doesn’t it?(W4)"(GT1).
“- In addition there is the experience. It’s probably part
of the art....It’s our work. In PC, our work is the clinical
interview. We have to know, aside from diagnosing the
patient, what he or she feels, and empathize with the
person.. (M1).-...One sees it at times as dogma... what I
mean is that not all patients are the same and many
times you are in front of a patient that EBM says has
this or that, and you don’t see it! Experience is also
worth a lot!” (W4)(GTR2).
From this perspective, “experience” was related to the
“art” of medicine, to the management of uncertainty,
and to empathy in communication with the patient. All
these aspects were considered especially important in
PC and different from other specialties located at Hospi-
tals. The need to respond to clinical practice problems
that have no clear answers in the CPGs stressed the
importance of the meaning of “experience” as a neces-
sary component of the “good patient care“.
“-In spite of clinical evidence being there and telling
you what to do, then you clash with the subjectivity of
the relationship with the patient...and that also produces
a certain frustration and leads you to think that EBM
does not work .... (M3)
- Anyway I believe that this same forum with oncolo-
gists would be different, because in other branches of
medicine they live in the most absolute certainty...
(M5)"(GS1).
“- I think that medicine is not only a science. It’sa n
art. Since it’s also an art, it is clear that not everything
can be based on scientific evidence... and that many
times you need to negotiate, make pacts, there’sal o to f
that. Medicine does not have to be 2 × 2 = 4. Medicine
is something else, isn’t it?... (W2)
- But then there are many small consultations for which
we don’t have guidelines! There are no guidelines for all
consultations. There may be some sort of orientation, but
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EBM.(W7)” (GT2).
2) EBM: Context and interests
Perceptions about the context in which physicians work
made up a second area of results that included two
schematic sub-areas (Figure 2). The first of these repre-
sented patient care within the consultation room,w h e r e
clinical questions arise and decisions are made. The sec-
ond, necessarily related to the first, tried to show the
diverse paths from “outside” the consultation room,t h a t
is, beyond the relationship with the patient, that espe-
cially condition the use of EBM in PC.
With respect to the work within the consultation room
all groups agreed about the excessive workload and the
lack of time for routine use of EBM. These obstacles
were added to other difficulties such as the lack of
resources, educational gaps and limitations in areas such
as English or information technologies. Under such cir-
cumstances, EBM seemed to be more widely used in the
area of training.
“... ok, it’s important, but it takes up a little space in
our everyday work, and above all due to lack of time,
doesn’t it? If you have 30-40-50 patient visits, logically
you’re not going to do anything about EBM at that
time.” (M2)(GTR1).
“...for me the language is also important; if they give
you a guideline in Spanish, or in English, it makes a dif-
ference...” (W1)(GTR4).
“We really do what we can in the daily office visits,
but when the Residents are there I think we make an
effort to really apply EBM, in order to train them.” (W4)
(GT2).
From “outside” the consultation one of the conditional
factors for using the EBM and CPGs was their linkage
to economic efficiency and control promoted by
management.
“It seems that EBM has been focused a little on the
drugs we give or we don’t give, because behind that there
is a cost, and we also have the manager that harps on
us about it..."(W5)(GTR1)
“...Because you feel they are controlling your work!
They compare what you do with respect to the guidelines
or the evidence. I think there is a sensation of threat, or
even of resistance to... I’ve always done it this way (M2).”
(GTR2)
What’s objective
EBM=scientific experience
The art of 
medical practice
What works
but has no
“evidence”
Good patient care
Knowledge,
bedside manner
EBM, context
and interests
EBM, doubt and trust
Uncertainty
What’s published
Methods change
What’s numerical
Trust,
security,
tranquility
Figure 1 EBM: science, experience and good patient care.
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industry constituted the “external factor” that most
repeatedly appeared in connection with the use of EBM.
EBM seemed to represent an important tool to neutra-
lize its influence, helping to reveal the biases and gaps
in misleading advertising.
“...because of course, the truth is that pharmaceutical
companies or large institutions blatantly fool us. ...So EBM
has his base on something that has been demonstrated
before and that doesn’t camouflage in statistics.” (M2)(GT1).
“I believe industry does a good job. They are private
institutions whose goal is to make money. Our job is to
be able to filter that a bit. To begin with, we must not
believe a word of what the industry says.” (M1)(GS2).
EBM was also perceived as a useful instrument to
curb the influence of specialized healthcare and the pri-
vate sector, allowing the physicians to question their cri-
teria. And finally, the influence of the media and
possible claims from the patients were also “external”
motives to accept the security that EBM provides in
case of unjustified requests.
“- The problem is also that for example, we have to
prescribe things referred from specialists... EBM helps in
this, and what I do is, based on the evidence, say to my
patient that there is no scientific evidence that has pro-
ven this, and sometimes I do this so as not to continue
prescribing a medication.(W6)
-...This has brought to my mind the matter of the risk
that we often have of making medical mistakes, don’t
w e ? . . .A n dt h a tE B Mc o u l dh e l py o uab i t ,s oy o uc a n
feel that if you have a claim from a patient because of a
medical error, at least you have based your actions on
EBM! (W2)(GT2).
“Yes we use it, but especially to deny treatments. To
justify a decision when there is concern about it, espe-
cially in our case the medications prescribed by private
physicians, don’t we?” (W3)(GTR1).
Consequently, on one hand, EBM was seen as a “pro-
active“ instrument that helps to achieve a good practice
despite clear limitations derived from the conditions of
PC consultations. On the other hand, however, and often
more importantly, EBM was considered a “reactive“
Private
medicine
Specialists
EBM, doubt and trust
EBM, science
and experience
Teaching
Scarce resources
Language (English)
Computer skills
Management / 
economic efficiency /
supervision
Lack of time
Pro-regulatory action
Defensive reaction
“outside” the 
consultation
the consultation
Claims
The media
QUESTIONS
ANSWERS
Pharmaceutical
industry
Training gaps
Figure 2 EBM: context and interests.
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the consultation, and even from “outside” the real
patients’ needs.
3) EBM: doubt and trust
Findings in the discourses in the third area showed a
somewhat paradoxical scenario, especially in groups that
had a greater prior knowledge of EBM. As mentioned
previously, perceptions of EBM included a questioning
attitude component that led FPs to review the scientific
basis of many clinical norms. This “tendency to doubt“
(Figure 3) was heightened by the unlimited growth of the
published literature which is very difficult to access and
select. For this reason published evidence was often seen
as biased or provisional.
“- At times the evidence can be easily manipulated,
can’t it? It’s not the same thing to say what is the evi-
dence now than in 10 years time (W2).
-Id o n ’t dare to talk about some things... medications
no!, use this!, and in a few years there’s been another
study and I don’t know what... and then you treat the
condition in a different manner (W5).” (GT1)
“I believe this has turned us into “doubt experts”,
because I had not thought that one should continuously
doubt.” (W1)(GT2).
Family practitioners’ doubts increased when different
CPGs gave different recommendations for the same pro-
blem even though they all claimed to be based on EBM.
In such situations FPs stated they looked for reliable
references to help reduce their uncertainty. They did not
want to be involved in searching and discriminating the
evidence, but they needed to trust those who write GPCs
and other EBM products. The grounds for trust, accord-
ing to the FPs, were that guidelines should be “aseptic” (i.
e. free of conflicts of interests related to the pharmaceuti-
cal industry, for example), have institutional validation,
and be developed by a close and well known source.
“I am reviewing now for a manual and there are two
American guidelines that are totally contradictory. They
both claim to be based on evidence and they both give
type A recommendations. Which one is correct? What
evidence can you trust? (M1)(GS2).
“...I’m not going to check out all the studies. I have to
trust someone who does that work. It makes things easier
for me.” (W1)(GTR3).
“- Who validates this? It should be the most aseptic,
shouldn’ti t ?S oy o ui m a g i n eav e r ya s e p t i cs c i e n t i f i c
association because it has nothing to do with the indus-
try or with the administration, although this is not
always so, but well....(W3)
Diffícult to manage 
publications
tendency
to doubt
Aseptic
reliable
delegation
The micropower
of EBM/
the “believers”
EBM, science
and experience
EBM, context
and interests
Information is
provisional
Variability of
recommendations
Institutional
Closeness
Producers (“evidence experts”)
/ Users (clinicians)
Questioning /
suspicion New methods or
new experts?
Figure 3 EBM, doubt and trust.
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check some clinical guidelines, maybe you rely more on
the Catalonian one because you are from Catalonia...
(W1)” (GTR1).
Discourses from the different groups thus reflected at
least two types of professionals: those that “use EBM”,
the majority, and those that “make EBM”.T h o s et h a t
“make” E B Mw e r ec o n s i d e r e dan e wk i n do fe x p e r t so r
“evidence experts”, expected to produce reliable tools
t h a ta r ee a s yt oa p p l yi nd a i l yw o r k .A n da m o n gt h e
users a new kind of “believers” also appeared, conscious
of their different knowledge status.
“I leave this in the hands of the evidence experts. That
you have to recommend aspirin here and recommend it
there, I believe him! I don’t wonder how he/she reached
that conclusion nor if there is evidence. I believe it.”
(M1)(GTR2).
“Id o n ’t pretend to be an expert. I think it’s ok that
p e o p l er e q u e s tg u i d e st h a th a v eb e e nt h o r o u g h l yg o n e
o v e r .A tl e a s tl e tm ek n o wi fi th a sa nA 1l e v e lo raB 2
level, don’t tell me where it comes from. Most of us are
believers, what the (EBM) group tells me I believe it...”.
(M5)(GS1).
The doubt and trust dimensions revealed a paradox
based on diverse arguments. FPs tended to be suspicious
of the vast amount and disparity of material published
under the EBM label, and thus somewhat sceptical to
change. However, their behaviour also showed an
increasing demand for EBM in an “easy”, “clear”, “cook-
book type” CPG format. Their trust appeared to depend
more on the degree of closeness with the new “experts”
involved in their development of EMB than on the use
of a different method for the acquisition and application
of knowledge.
Discussion
The present results come from the discourses of FPs
who agreed to participate in the discussion groups.
Although this presupposes towards attitudes of colla-
boration and availability that may not be generalized, it
adds a special value to the study of their perceptions.
Their different origins and degree of knowledge about
EBM and their extensive work experience enabled an
in-depth search of shared opinions and revealed new
areas for debate.
EBM and primary care: not only a question of barriers
Analysis of the participants’ discourses gives a dynamic
view toward implementing EBM in PC. As observed in
previous studies, EBM is perceived as positive in most
groups [8,9,11,14] Its interpretation, however, is not
based on a precise definition of EBM but is constructed
over time in daily practice from a set of experiences and
issues concerning its usefulness.
Workload pressure, lack of time, limited computer
expertise and training in EBM, and a lack of knowledge
of English in our environment have also been identified
in other studies as the main barriers to the implementa-
tion of EBM [8,11,14]. In our opinion these obstacles are
closely related to access and management of information
but cannot fully account for the limited incorporation of
EBM in daily practice.
Implementation is also conditioned by what we
denominated a “defensive reaction” whose origins were
found mainly “outside” t h ec o n s u l t a t i o n .T h er o l eo f
EBM as a “reactive” tool to the pressure of the pharma-
ceutical industry, to its connection with money saving
and managerial policies, and to its use to neutralize the
influence of other specialists, the media and even the
claims of patients, together create a scenario that goes
beyond the search for information [17,28]. It would
therefore be reasonable to question whether the term
“barriers” is the most appropriate summary-metaphor of
the difficulties for change in the EBM field [29]. The
“reactive” use of EBM can determine not only the
answers but also the FPs’ questions themselves, or in
other words, the kind of demands for using the EBM can
condition the kind of resultant EBM. Decisions about
which type of intervention, medication or care should be
reviewed and evaluated on the basis of EBM appear to be
conditioned by the above factors, all of which contribute
to “EBM sensemaking” in PC. Connecting the mentioned
“reactive” focus with the context in which EBM is devel-
oped opens the debate towards health policies and orga-
nizational strategies [3]. In addition to measures intended
to improve the search and management of information, a
“pro-active” development of EBM would be advisable to
respond to the specific priorities of PC. Good patient
care should be the bottom line when it comes to deciding
which questions need to be answered and determining
the criteria for their assessment.
Science, EBM, and the new experts
For FPs EBM represents a model of care that is based on
“science” and it is seen as connected to objectivity, publi-
cation and numbers. However, in view of the limited
recognition of empirically important aspects such as
empathy, individualization, continuing patient-doctor
relationship, and the lack of CPG with specific recom-
mendations for the different kinds of patients, FPs con-
sider EBM is only a part of what could be considered
optimal clinical practice [12,30]. They consider “experi-
ence” is also an essential part and that it is not taken into
account in EBM or “science”.T h i se x c l u s i o ng e n e r a t e s
discomfort and tensions in the FPs’ discourses in a simi-
lar sense described by Cassell regarding clinicians’ roles
as scientists and care-givers [31]. Many of the contents
related to “experience” can also concur with the features
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Benzing [32], as a different, but complementary paradigm
to EBM. This questioning reflects the predominance of a
view of science and evidence which excludes, or relegates
to the lowest level in the hierarchy, many typical PC
actions that are based on values or that cannot be experi-
mentally studied. The need to develop other views of evi-
dence according to the complexity of clinical practice
emerges as a challenge for PC [12,13,33,34].
Our findings also suggest that certain components of
scientific practice, such as reflection and critical question-
ing, appear to be at risk. The demand for clear and practi-
cal “cookbook” type CPGs can be insufficient for the
implementation of EBM [19,35] at least as a method and
attitude for searching and appraising the best for patients’
care. The delegation to “make EBM” to the “new evidence
experts”, more or less closer to FPs but on a different sta-
tus, also leads us to wonder whether questioning the texts
and experts’ authority, as a foundation of EBM, would be
in danger of being substituted in practice by new text for-
mats and a new experts’ authority.
Under such circumstances, and keeping in mind the
marked influence of the pharmaceutical industry, man-
agement health policies, and other professional lobbies,
the frequent mention of contradictory recommendations
“based on the best evidence” inevitably conditions the
“tendency to doubt” the objectivity and neutrality of the
new experts [20], and indirectly, of EBM itself. Repercus-
sions are important because of their possible paradoxical
effect as an excuse for not changing.
Besides transparency in the production of GPCs and
other EBM tools [20,36], we need to promote deeper
debate among FPs on the theoretical basis of EBM
[4,37,38] and its role in real clinical practice [39] in
order to improve good patient care in PC.
Conclusions
The meaning of EBM is dynamically constructed by FPs
within the primary care context from the experiences
concerning its usefulness in their daily practice. EBM, as
a model of care based on “science”, represents only a part
of good clinical practice. “Experience” emerges also as
another essential part that resumes many typical PC
actions that are based on values or that cannot be experi-
mentally studied. The current views of evidence and
science among the FPs should be discussed and devel-
oped according to the complexity of PC.
Difficulties for change in the EBM field go beyond the
“barriers” related to lack of time, training and informa-
tion access. The use of EBM is also conditioned by its
role as a “defensive tool” faced with the pressure of the
pharmaceutical industry, with its connection with
money saving and managerial policies, and with its use
to neutralize the influence of other specialists, the media
and even the claims of patients. This “reactive” EBM
sensemaking can determinen o to n l yt h ea n s w e r sb u t
also the questions addressed to EBM. A more “pro-
active” and patient-centered development of EBM would
be advisable at PC level.
Along with concerns about its objectivity, there arises
a tendency to see EBM as the use of simplified guide-
lines developed by EBM experts. Contradictory recom-
mendations “based on the best evidence” condition a
“tendency to doubt” about the objectivity and neutrality
of EBM. Transparency in the production of GPCs and
other EBM tools comes up as necessary, and also it
emerges the question whethers o m eo ft h et h e o r e t i c a l
foundations of EBM are in danger of being substituted
by new text formats and a new profile of experts.
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